Implementation of precision cancer medicine and economic evaluation for Health Technology Assessment
Implementation of precision cancer medicine and economic evaluation for Health Technology Assessment (HTA) – what are the challenges and how do we address them?
Official Opening of the Horizon EU Cancer Mission PRIME-ROSE project
The PRIME-ROSE kick-off took place in Oslo on September 19-20 and gathered around 70 participants from different partners across Europe.
PRIME-ROSE kick-off event 19-20 September
Testbed Sweden Precision Cancer is attending the PRIME-ROSE kick-off in Oslo right now!
Nordic Precision Cancer Medicine Conference
We are looking forward to participating at the Nordic Precision Cancer Medicine conference in Oslo during next week.
Se vårt seminarium från Almedalen
Missade du vårt seminarium i Almedalen. Hälsa och Cancervård med precision - har vi kompetensen? då kan du se det här!
PRIME-ROSE: EU project receives 6 million EUR from EU Cancer Mission
PRIME-ROSE - A European precision cancer medicine trial network and implementation initiative funded by the EU Cancer Mission. The project was approved by the European Commission om April 23 2023.
Join us for the EU Cancer Mission Day - Ireland, advancing the fight against cancer and improving lives.
Join us for the EU Cancer Mission Day - Ireland, advancing the fight against cancer and improving lives.
LAUNCH: Welcome to the PRIME-ROSE LinkedIn site!
We are excited to be part of the growing DLCT (DRUP-Like Clinical Trial) Community and are looking forward to start working on the implementation of precision medicine for all patients in Europe!
Almedalen 2023
Wednesday June 28, Testbed Sweden Precision Health is hosting an event at Almedalen. Almedalen takes place each year in Sweden in the city of Visby at the island of Gotland and is the world's largest democratic meeting place for social issues.
Great to be involved in not one but actually two European sister projects!
Great meeting with European Medicines Agency discussing the PRIME-ROSE and PCM4EU - Personalised Cancer Medicine for all EU citizens projects!
We are delighted to be part the PCM4EU project!
Visit the PCM4EU webbsite: Combining expertise across borders to promote Precision Cancer Medicine i Europe.
The first PCM4EU podcast episodes are live!
In episode 2 and 3, we meet Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, PhD and Pharmacist, Medicine & Society at CZ Health Insurance and Member of the National Payer’s Evaluation Committee for Specialized Medicines and Companion Diagnostics (CieBAG).
Press release: PRIME-ROSE is now approved by the European Commission
PRIME-ROSE - A European precision cancer medicine trial network and implementation initiative funded by the EU Cancer Mission. The project was approved by the European Commission om April 23 2023.
Europe’s Beating Cancer: implementation roadmap
he European Commission has published an implementation roadmap and progress indicators for Europe’s Beating Cancer Plan to monitor developments on the ten flagship initiatives as well as its other actions.
Sweden launches testbed for clinical trials in cancer care
Vision Zero Cancer and Genomic Medicine Sweden (GMS) join forces with SciLifeLab, public sector authorities, regions, healthcare, academia, industry and patient associations to create an innovation milieu that facilitates the introduction of more precise prevention and treatment in cancer care.